MORGAN STANLEY PLC/CALL/NOVARTIS N/97.5/0.1/20.12.24 Share Price

Warrant

DE000ME1WHF5

Real-time Bid/Ask 08:38:09 02/07/2024 pm IST
0.43 EUR / 0.44 EUR +6.10% Intraday chart for MORGAN STANLEY PLC/CALL/NOVARTIS N/97.5/0.1/20.12.24
1 month+41.38%
3 months+131.64%
Date Price Change
02/24/02 0.42 +2.44%
01/24/01 0.41 +5.13%
28/24/28 0.39 -2.50%
27/24/27 0.4 -6.98%
26/24/26 0.43 +2.38%

Delayed Quote Börse Stuttgart

Last update July 02, 2024 at 06:21 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying NOVARTIS AG
Issuer Morgan Stanley
WKN ME1WHF
ISINDE000ME1WHF5
Date issued 11/10/2023
Strike 97.5 CHF
Maturity 20/12/2024 (171 Days)
Parity 10 : 1
Emission price 0.43
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.45
Lowest since issue 0.13
Spread 0.01
Spread %2.33%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
107 USD
Average target price
110.3 USD
Spread / Average Target
+3.05%
Consensus